Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways

Journal of Nutritional Biochemistry

Volumn 25, Issue 9, 2014, Pages 934-945

  Chiu, Shao Chih ^a,b   Chiang, En Pei Isabel ^c,f   Tsai, Shu Yao ^c   Wang, Fu Yu ^d   Pai, Man Hui ^a   Syu, Jia Ning ^d   Cheng, Ching Chang ^d   Rodriguez, Raymond L ^e   Tang, Feng Yao ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; C kit; Eicosapentaenoic acid; ENOS; Human endothelial progenitor cells; MicroRNA 221; Neovasculogenesis

Indexed keywords

DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ICOSAPENTAENOIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NUDE MOUSE; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALIA;

ANIMALS; CELLS, CULTURED; EICOSAPENTAENOIC ACID; ENDOTHELIAL PROGENITOR CELLS; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84905217171     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.04.007     Document Type: Article

References (35)

1. Choi K. The hemangioblast: a common progenitor of hematopoietic and endothelial cells. J Hematother Stem Cell Res 2002, 11:91-101.
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Asahara T., Isner J.M. Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 2002, 11:171-178.
4. Asahara T. Endothelial progenitor cells for neovascularization. Ernst Schering Research Foundation workshop 2003, 211-216.
5. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004, 287:C572-C579.
6. Nishimura H., Asahara T. Bone marrow-derived endothelial progenitor cells for neovascular formation. EXS 2005, 147-154.
7. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
8. Masuda H., Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003, 58:390-398.
9. Kawamoto A., Murayama T., Kusano K., Ii M., Tkebuchava T., Shintani S., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 2004, 110:1398-1405.
10. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
11. Barua R.S., Ambrose J.A., Eales-Reynolds L.J., DeVoe M.C., Zervas J.G., Saha D.C. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001, 104:1905-1910.
12. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005, 45:1441-1448.
13. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
14. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
15. Matsui J., Wakabayashi T., Asada M., Yoshimatsu K., Okada M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 2004, 279:18600-18607.
16. Linnekin D. Early signaling pathways activated by c-kit in hematopoietic cells. Int J Biochem Cell Biol 1999, 31:1053-1074.
17. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
18. Kim K.L., Meng Y., Kim J.Y., Baek E.J., Suh W. Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells. Cardiovasc Res 2011, 92:132-140.
19. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
20. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
21. Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P., et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005, 310:1817-1821.
22. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006, 11:441-450.
23. Pasquinelli A.E., Hunter S., Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev 2005, 15:200-205.
24. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 2012, 52:245-255.
25. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
26. Chiang E.P., Chiu S.C., Pai M.H., Wang Y.C., Wang F.Y., Kuo Y.H., et al. Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of MicroRNA 221 and the PI3-K/Akt signaling pathways. J Agric Food Chem 2013, 61:4839-4849.
27. Minami Y., Satoh M., Maesawa C., Takahashi Y., Tabuchi T., Itoh T., et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Investig 2009, 39:359-367.
28. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
29. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
30. Saravanan P., Davidson N.C., Schmidt E.B., Calder P.C. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376:540-550.
31. Huang P.H., Chen Y.H., Wang C.H., Chen J.S., Tsai H.Y., Lin F.Y., et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009, 29:1179-1184.
32. Tang F.Y., Chiang E.P., Shih C.J. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. J Nutr Biochem 2007, 18:391-399.
33. Tang F.Y., Meydani M. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr Cancer 2001, 41:119-125.
34. Tang F.Y., Nguyen N., Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003, 106:871-878.
35. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.